Antiplatelet drugs and COVID-19: use for prevention of arterial vascular complications in different time periods of the disease
- Issue: Vol 93, No 12 (2021)
- Pages: 1562-1563
- Section: Conference proceedings
- URL: https://bakhtiniada.ru/0040-3660/article/view/96512
- ID: 96512
Cite item
Full Text
Abstract
A Council of Experts was held in Moscow with the scientific and organizational support of the National Medical Research Center for Therapy and Preventive Medicine and the Russian Society for the Prevention of Noncommunicable Diseases. Leading experts in various fields of medicine discussed the possibility of using antiplatelet drugs as prevention of arterial vascular complications of COVID-19 in different time periods of the disease. The main outcome of the Council of Experts was a resolution reflecting the general view of the scientific community on the possibility of increasing the use of acetylsalicylic acid in patients with coronavirus infection.
Full Text
##article.viewOnOriginalSite##References
- Арутюнов Г. П., Тарловская Е. И., Арутюнов А. Г. и соавт. Международный регистр “Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (AКТИВ SARS-CoV-2)”: анализ 1000 пациентов. Российский кардиологический журнал. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. 2020;25(11):4165 (in Russian)]2020;25(11):4165. doi: 10.15829/1560-4071-2020-4165
- Резолюция Совета экспертов по обмену научным опытом применения антиагрегантов, включая ацетилсалициловую кислоту, в качестве профилактики артериальных сосудистых осложнений COVID-19 в разные периоды заболевания. Терапия. 2021;9:113-24 [Resolution of the Council of experts on scientific experience exchange of antiplatelet drugs use, including acetylsalicylic acid for prevention of COVID-19 arterial vascular complications in different time of the disease. Therapy. 2021;9:113-24 (in Russian)]. https://dx.doi.org/10.18565/therapy.2021.9.113-124
Supplementary files
